Check out the latest podcast from @thecovaxfiles which explores #COVID19 vaccine manufacturing delays and hear from @FionaReporter https://t.co/zQArYF82hZ
#GlobalData reveals 10 key #pharma themes in 2021 with #COVID19, remote patient monitoring and drug pricing and reimbursement to have greatest impact on industry, https://t.co/Mz82RHI6JK
Est 330m people, 15% of the 9MM population, face risk of severe COVID-19, says GlobalData Epidemiologists, read Katie Wrenn Associate Epidemiologist at GlobalData views on the current challenges facing the 9MM https://t.co/5UflZ1eu9j
Our latest report reveals that 49% of global industry survey respondents believe that #drug#pricing and #reimbursement constraints will have the greatest negative impact on the #pharmaceutical industry in 2020. Find out more here: https://t.co/CcUg9GdgwB
The total prevalent cases of chronic obstructive pulmonary #disease in the seven major markets is expected to increase from 59.3 million cases in 2018 to 67.2 million in 2028, at an annual growth rate of 1.33%. Read the latest here: #COPD https://t.co/Uf6gMoBhmS
Diagnosed prevalent cases of chronic heart failure to reach 32 million by 2028 in the 8MM, says GlobalData
https://t.co/mgXVTVJJjq
#HeartFailure#healthcare
The global medical marijuana market is expected to reach $3.2 billion US dollars by 2025, find out more about why this market is set to experience such astronomical growth: https://t.co/AKBDfRlgJY
#GlobalData has ranked the most popular health-related websites in the world by the average amount of monthly visits to the site, according to #SimilarWeb. #digitalhealth
European Society of Cardiology/Heart Failure Association position paper on the role and safety of new glucose‐lowering drugs in patients with heart failure https://t.co/HS3DnL4JML